世界の涙嚢炎治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Dacryocystitis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1709 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、涙嚢炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口抗生物質、全身抗生物質、手術、その他）、用途別市場規模（急性涙嚢炎、慢性涙嚢炎、先天性涙嚢炎、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・涙嚢炎治療の市場動向 ・企業の競争状況、市場シェア ・涙嚢炎治療の種類別市場規模（経口抗生物質、全身抗生物質、手術、その他） ・涙嚢炎治療の用途別市場規模（急性涙嚢炎、慢性涙嚢炎、先天性涙嚢炎、その他） ・涙嚢炎治療の北米市場規模2016-2027（アメリカ、カナダ） ・涙嚢炎治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・涙嚢炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・涙嚢炎治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・涙嚢炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Abbott Laboratories、Glaxosmithkline、Mylan、Cipla、FCI Ophthalmics、Aurolab、Kaneka、Gunther Weiss Scientific Glass、Bess Medizintechnik GmbH） ・結論

Market Analysis and Insights: Global Dacryocystitis Treatment Market
The global Dacryocystitis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dacryocystitis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dacryocystitis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dacryocystitis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dacryocystitis Treatment market.

Global Dacryocystitis Treatment Scope and Market Size
Dacryocystitis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dacryocystitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral Antibiotics
Systemic Antibiotics
Surgery
Other

Segment by Application
Acute Dacryocystitis
Chronic Dacryocystitis
Congenital Dacryocystitis
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Abbott Laboratories
Glaxosmithkline
Mylan
Cipla
FCI Ophthalmics
Aurolab
Kaneka

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dacryocystitis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Antibiotics
1.2.3 Systemic Antibiotics
1.2.4 Surgery
1.2.5 Other
1.3 Market by Application
1.3.1 Global Dacryocystitis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Acute Dacryocystitis
1.3.3 Chronic Dacryocystitis
1.3.4 Congenital Dacryocystitis
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Dacryocystitis Treatment Market Perspective (2016-2027)
2.2 Dacryocystitis Treatment Growth Trends by Regions
2.2.1 Dacryocystitis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Dacryocystitis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Dacryocystitis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Dacryocystitis Treatment Industry Dynamic
2.3.1 Dacryocystitis Treatment Market Trends
2.3.2 Dacryocystitis Treatment Market Drivers
2.3.3 Dacryocystitis Treatment Market Challenges
2.3.4 Dacryocystitis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Dacryocystitis Treatment Players by Revenue
3.1.1 Global Top Dacryocystitis Treatment Players by Revenue (2016-2021)
3.1.2 Global Dacryocystitis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Dacryocystitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dacryocystitis Treatment Revenue
3.4 Global Dacryocystitis Treatment Market Concentration Ratio
3.4.1 Global Dacryocystitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dacryocystitis Treatment Revenue in 2020
3.5 Dacryocystitis Treatment Key Players Head office and Area Served
3.6 Key Players Dacryocystitis Treatment Product Solution and Service
3.7 Date of Enter into Dacryocystitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Dacryocystitis Treatment Breakdown Data by Type
4.1 Global Dacryocystitis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Dacryocystitis Treatment Forecasted Market Size by Type (2022-2027)

5 Dacryocystitis Treatment Breakdown Data by Application
5.1 Global Dacryocystitis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Dacryocystitis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Dacryocystitis Treatment Market Size (2016-2027)
6.2 North America Dacryocystitis Treatment Market Size by Type
6.2.1 North America Dacryocystitis Treatment Market Size by Type (2016-2021)
6.2.2 North America Dacryocystitis Treatment Market Size by Type (2022-2027)
6.2.3 North America Dacryocystitis Treatment Market Size by Type (2016-2027)
6.3 North America Dacryocystitis Treatment Market Size by Application
6.3.1 North America Dacryocystitis Treatment Market Size by Application (2016-2021)
6.3.2 North America Dacryocystitis Treatment Market Size by Application (2022-2027)
6.3.3 North America Dacryocystitis Treatment Market Size by Application (2016-2027)
6.4 North America Dacryocystitis Treatment Market Size by Country
6.4.1 North America Dacryocystitis Treatment Market Size by Country (2016-2021)
6.4.2 North America Dacryocystitis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Dacryocystitis Treatment Market Size (2016-2027)
7.2 Europe Dacryocystitis Treatment Market Size by Type
7.2.1 Europe Dacryocystitis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Dacryocystitis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Dacryocystitis Treatment Market Size by Type (2016-2027)
7.3 Europe Dacryocystitis Treatment Market Size by Application
7.3.1 Europe Dacryocystitis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Dacryocystitis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Dacryocystitis Treatment Market Size by Application (2016-2027)
7.4 Europe Dacryocystitis Treatment Market Size by Country
7.4.1 Europe Dacryocystitis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Dacryocystitis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Dacryocystitis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Dacryocystitis Treatment Market Size by Type
8.2.1 Asia-Pacific Dacryocystitis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Dacryocystitis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Dacryocystitis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Dacryocystitis Treatment Market Size by Application
8.3.1 Asia-Pacific Dacryocystitis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Dacryocystitis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Dacryocystitis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Dacryocystitis Treatment Market Size by Region
8.4.1 Asia-Pacific Dacryocystitis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Dacryocystitis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Dacryocystitis Treatment Market Size (2016-2027)
9.2 Latin America Dacryocystitis Treatment Market Size by Type
9.2.1 Latin America Dacryocystitis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Dacryocystitis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Dacryocystitis Treatment Market Size by Type (2016-2027)
9.3 Latin America Dacryocystitis Treatment Market Size by Application
9.3.1 Latin America Dacryocystitis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Dacryocystitis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Dacryocystitis Treatment Market Size by Application (2016-2027)
9.4 Latin America Dacryocystitis Treatment Market Size by Country
9.4.1 Latin America Dacryocystitis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Dacryocystitis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Dacryocystitis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Dacryocystitis Treatment Market Size by Type
10.2.1 Middle East & Africa Dacryocystitis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Dacryocystitis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Dacryocystitis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Dacryocystitis Treatment Market Size by Application
10.3.1 Middle East & Africa Dacryocystitis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Dacryocystitis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Dacryocystitis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Dacryocystitis Treatment Market Size by Country
10.4.1 Middle East & Africa Dacryocystitis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Dacryocystitis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Dacryocystitis Treatment Introduction
11.1.4 Pfizer Revenue in Dacryocystitis Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Dacryocystitis Treatment Introduction
11.2.4 Abbott Laboratories Revenue in Dacryocystitis Treatment Business (2016-2021)
11.2.5 Abbott Laboratories Recent Development
11.3 Glaxosmithkline
11.3.1 Glaxosmithkline Company Details
11.3.2 Glaxosmithkline Business Overview
11.3.3 Glaxosmithkline Dacryocystitis Treatment Introduction
11.3.4 Glaxosmithkline Revenue in Dacryocystitis Treatment Business (2016-2021)
11.3.5 Glaxosmithkline Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Mylan Business Overview
11.4.3 Mylan Dacryocystitis Treatment Introduction
11.4.4 Mylan Revenue in Dacryocystitis Treatment Business (2016-2021)
11.4.5 Mylan Recent Development
11.5 Cipla
11.5.1 Cipla Company Details
11.5.2 Cipla Business Overview
11.5.3 Cipla Dacryocystitis Treatment Introduction
11.5.4 Cipla Revenue in Dacryocystitis Treatment Business (2016-2021)
11.5.5 Cipla Recent Development
11.6 FCI Ophthalmics
11.6.1 FCI Ophthalmics Company Details
11.6.2 FCI Ophthalmics Business Overview
11.6.3 FCI Ophthalmics Dacryocystitis Treatment Introduction
11.6.4 FCI Ophthalmics Revenue in Dacryocystitis Treatment Business (2016-2021)
11.6.5 FCI Ophthalmics Recent Development
11.7 Aurolab
11.7.1 Aurolab Company Details
11.7.2 Aurolab Business Overview
11.7.3 Aurolab Dacryocystitis Treatment Introduction
11.7.4 Aurolab Revenue in Dacryocystitis Treatment Business (2016-2021)
11.7.5 Aurolab Recent Development
11.8 Kaneka
11.8.1 Kaneka Company Details
11.8.2 Kaneka Business Overview
11.8.3 Kaneka Dacryocystitis Treatment Introduction
11.8.4 Kaneka Revenue in Dacryocystitis Treatment Business (2016-2021)
11.8.5 Kaneka Recent Development
11.9 Gunther Weiss Scientific Glass
11.9.1 Gunther Weiss Scientific Glass Company Details
11.9.2 Gunther Weiss Scientific Glass Business Overview
11.9.3 Gunther Weiss Scientific Glass Dacryocystitis Treatment Introduction
11.9.4 Gunther Weiss Scientific Glass Revenue in Dacryocystitis Treatment Business (2016-2021)
11.9.5 Gunther Weiss Scientific Glass Recent Development
11.10 Bess Medizintechnik GmbH
11.10.1 Bess Medizintechnik GmbH Company Details
11.10.2 Bess Medizintechnik GmbH Business Overview
11.10.3 Bess Medizintechnik GmbH Dacryocystitis Treatment Introduction
11.10.4 Bess Medizintechnik GmbH Revenue in Dacryocystitis Treatment Business (2016-2021)
11.10.5 Bess Medizintechnik GmbH Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Dacryocystitis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Antibiotics
Table 3. Key Players of Systemic Antibiotics
Table 4. Key Players of Surgery
Table 5. Key Players of Other
Table 6. Global Dacryocystitis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Dacryocystitis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Dacryocystitis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Dacryocystitis Treatment Market Share by Regions (2016-2021)
Table 10. Global Dacryocystitis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Dacryocystitis Treatment Market Share by Regions (2022-2027)
Table 12. Dacryocystitis Treatment Market Trends
Table 13. Dacryocystitis Treatment Market Drivers
Table 14. Dacryocystitis Treatment Market Challenges
Table 15. Dacryocystitis Treatment Market Restraints
Table 16. Global Dacryocystitis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Dacryocystitis Treatment Market Share by Players (2016-2021)
Table 18. Global Top Dacryocystitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dacryocystitis Treatment as of 2020)
Table 19. Ranking of Global Top Dacryocystitis Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Dacryocystitis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Dacryocystitis Treatment Product Solution and Service
Table 23. Date of Enter into Dacryocystitis Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Dacryocystitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Dacryocystitis Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Dacryocystitis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Dacryocystitis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Dacryocystitis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Dacryocystitis Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Dacryocystitis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Dacryocystitis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Dacryocystitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Dacryocystitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Dacryocystitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Dacryocystitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Dacryocystitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Dacryocystitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Dacryocystitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Dacryocystitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Dacryocystitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Dacryocystitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Dacryocystitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Dacryocystitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Dacryocystitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Dacryocystitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Dacryocystitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Dacryocystitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Dacryocystitis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Dacryocystitis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Dacryocystitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Dacryocystitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Dacryocystitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Dacryocystitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Dacryocystitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Dacryocystitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Dacryocystitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Dacryocystitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Dacryocystitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Dacryocystitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Dacryocystitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Dacryocystitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Dacryocystitis Treatment Product
Table 66. Pfizer Revenue in Dacryocystitis Treatment Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Abbott Laboratories Company Details
Table 69. Abbott Laboratories Business Overview
Table 70. Abbott Laboratories Dacryocystitis Treatment Product
Table 71. Abbott Laboratories Revenue in Dacryocystitis Treatment Business (2016-2021) & (US$ Million)
Table 72. Abbott Laboratories Recent Development
Table 73. Glaxosmithkline Company Details
Table 74. Glaxosmithkline Business Overview
Table 75. Glaxosmithkline Dacryocystitis Treatment Product
Table 76. Glaxosmithkline Revenue in Dacryocystitis Treatment Business (2016-2021) & (US$ Million)
Table 77. Glaxosmithkline Recent Development
Table 78. Mylan Company Details
Table 79. Mylan Business Overview
Table 80. Mylan Dacryocystitis Treatment Product
Table 81. Mylan Revenue in Dacryocystitis Treatment Business (2016-2021) & (US$ Million)
Table 82. Mylan Recent Development
Table 83. Cipla Company Details
Table 84. Cipla Business Overview
Table 85. Cipla Dacryocystitis Treatment Product
Table 86. Cipla Revenue in Dacryocystitis Treatment Business (2016-2021) & (US$ Million)
Table 87. Cipla Recent Development
Table 88. FCI Ophthalmics Company Details
Table 89. FCI Ophthalmics Business Overview
Table 90. FCI Ophthalmics Dacryocystitis Treatment Product
Table 91. FCI Ophthalmics Revenue in Dacryocystitis Treatment Business (2016-2021) & (US$ Million)
Table 92. FCI Ophthalmics Recent Development
Table 93. Aurolab Company Details
Table 94. Aurolab Business Overview
Table 95. Aurolab Dacryocystitis Treatment Product
Table 96. Aurolab Revenue in Dacryocystitis Treatment Business (2016-2021) & (US$ Million)
Table 97. Aurolab Recent Development
Table 98. Kaneka Company Details
Table 99. Kaneka Business Overview
Table 100. Kaneka Revenue in Dacryocystitis Treatment Business (2016-2021) & (US$ Million)
Table 101. Kaneka Recent Development
Table 102. Gunther Weiss Scientific Glass Company Details
Table 103. Gunther Weiss Scientific Glass Business Overview
Table 104. Gunther Weiss Scientific Glass Dacryocystitis Treatment Product
Table 105. Gunther Weiss Scientific Glass Revenue in Dacryocystitis Treatment Business (2016-2021) & (US$ Million)
Table 106. Gunther Weiss Scientific Glass Recent Development
Table 107. Bess Medizintechnik GmbH Company Details
Table 108. Bess Medizintechnik GmbH Business Overview
Table 109. Bess Medizintechnik GmbH Dacryocystitis Treatment Product
Table 110. Bess Medizintechnik GmbH Revenue in Dacryocystitis Treatment Business (2016-2021) & (US$ Million)
Table 111. Bess Medizintechnik GmbH Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dacryocystitis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Oral Antibiotics Features
Figure 3. Systemic Antibiotics Features
Figure 4. Surgery Features
Figure 5. Other Features
Figure 6. Global Dacryocystitis Treatment Market Share by Application: 2020 VS 2027
Figure 7. Acute Dacryocystitis Case Studies
Figure 8. Chronic Dacryocystitis Case Studies
Figure 9. Congenital Dacryocystitis Case Studies
Figure 10. Other Case Studies
Figure 11. Dacryocystitis Treatment Report Years Considered
Figure 12. Global Dacryocystitis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Dacryocystitis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Dacryocystitis Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Dacryocystitis Treatment Market Share by Regions (2022-2027)
Figure 16. Global Dacryocystitis Treatment Market Share by Players in 2020
Figure 17. Global Top Dacryocystitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dacryocystitis Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Dacryocystitis Treatment Revenue in 2020
Figure 19. Global Dacryocystitis Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Dacryocystitis Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Dacryocystitis Treatment Market Share by Type (2016-2027)
Figure 23. North America Dacryocystitis Treatment Market Share by Application (2016-2027)
Figure 24. North America Dacryocystitis Treatment Market Share by Country (2016-2027)
Figure 25. United States Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Dacryocystitis Treatment Market Share by Type (2016-2027)
Figure 29. Europe Dacryocystitis Treatment Market Share by Application (2016-2027)
Figure 30. Europe Dacryocystitis Treatment Market Share by Country (2016-2027)
Figure 31. Germany Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Dacryocystitis Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Dacryocystitis Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Dacryocystitis Treatment Market Share by Region (2016-2027)
Figure 41. China Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Dacryocystitis Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Dacryocystitis Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Dacryocystitis Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Dacryocystitis Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Dacryocystitis Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Dacryocystitis Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Dacryocystitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Pfizer Revenue Growth Rate in Dacryocystitis Treatment Business (2016-2021)
Figure 61. Abbott Laboratories Revenue Growth Rate in Dacryocystitis Treatment Business (2016-2021)
Figure 62. Glaxosmithkline Revenue Growth Rate in Dacryocystitis Treatment Business (2016-2021)
Figure 63. Mylan Revenue Growth Rate in Dacryocystitis Treatment Business (2016-2021)
Figure 64. Cipla Revenue Growth Rate in Dacryocystitis Treatment Business (2016-2021)
Figure 65. FCI Ophthalmics Revenue Growth Rate in Dacryocystitis Treatment Business (2016-2021)
Figure 66. Aurolab Revenue Growth Rate in Dacryocystitis Treatment Business (2016-2021)
Figure 67. Kaneka Revenue Growth Rate in Dacryocystitis Treatment Business (2016-2021)
Figure 68. Gunther Weiss Scientific Glass Revenue Growth Rate in Dacryocystitis Treatment Business (2016-2021)
Figure 69. Bess Medizintechnik GmbH Revenue Growth Rate in Dacryocystitis Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---